Olympus Corporation (TYO:7733)
Japan · Delayed Price · Currency is JPY 2,110.50
+43.00 (2.08%)
Aug 14, 2026, 3:30 PM JST
Olympus Financials Overview
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Revenue Revenue Growth | 1,044,564 | 1,010,676 | 997,332 | 936,210 | 881,923 | 868,867 |
Revenue Growth | 7.80% | 1.34% | 6.53% | 6.16% | 1.50% | 18.93% |
Gross Profit Gross Profit Growth | 675,788 | 654,090 | 683,697 | 625,123 | 596,849 | 571,695 |
Operating Income Operating Income Growth | 150,396 | 136,676 | 167,419 | 114,222 | 172,084 | 168,550 |
Net Income Net Income Growth | 78,283 | 68,172 | 117,855 | 242,566 | 143,432 | 115,742 |
Earnings Per Share EPS Growth | 71.10 | 61.20 | 102.80 | 199.44 | 113.08 | 90.17 |
EPS Growth | -27.99% | -40.47% | -48.46% | 76.37% | 25.41% | 797.95% |
| Fiscal Year | TTM | FY 2026 | FY 2025 |
|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 |
Gastrointestinal Solutions Division Gastrointestinal Solutions Division Growth | 726,784 | 697,359 | 674,043 |
Surgical & Interventional Solutions Division Surgical & Interventional Solutions Division Growth | 317,604 | 313,109 | 322,759 |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Investments Cash & Investments Growth | 118,545 | 188,038 | 252,532 | 340,933 | 169,329 | 302,572 |
Total Debt Total Debt Growth | 318,892 | 239,576 | 229,102 | 299,616 | 340,057 | 386,127 |
Net Cash (Debt) Net Cash Growth | -200,347 | -51,538 | 23,430 | 41,317 | -170,728 | -83,555 |
Net Cash Growth | - | - | -43.29% | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -181.99 | -46.27 | 20.44 | 33.97 | -134.60 | -65.09 |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 130,122 | 100,585 | 190,463 | 42,365 | 98,490 | 169,729 |
Capital Expenditures CapEx Growth | -58,736 | -55,558 | -46,001 | -46,425 | -47,570 | -41,688 |
Free Cash Flow Free Cash Flow Growth | 71,386 | 45,027 | 144,462 | -4,060 | 50,920 | 128,041 |
Free Cash Flow Growth | -29.58% | -68.83% | - | - | -60.23% | 49.82% |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Gross Margin | 64.70% | 64.72% | 68.55% | 66.77% | 67.68% | 65.80% |
Operating Margin | 14.40% | 13.52% | 16.79% | 12.20% | 19.51% | 19.40% |
Pretax Margin | 10.02% | 9.30% | 15.95% | 3.83% | 20.67% | 17.25% |
Profit Margin | 7.49% | 6.74% | 11.82% | 25.91% | 16.26% | 13.32% |
FCF Margin | 6.83% | 4.46% | 14.49% | -0.43% | 5.77% | 14.74% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 15, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Dividend Per Share Dividend Per Share Growth | 30.000 | 30.000 | 20.000 | 18.000 | 16.000 | 14.000 |
Dividend Per Share Growth | 50.00% | 50.00% | 11.11% | 12.50% | 14.29% | 16.67% |
Dividend Yield | 1.45% | 2.02% | 1.05% | 0.84% | 0.72% | 0.63% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 15, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 29.68 | 24.04 | 18.64 | 10.63 | 20.26 | 25.73 |
Forward PE | 21.30 | 18.42 | 18.59 | 17.59 | 15.85 | 27.70 |
P/FCF Ratio | 31.42 | 36.40 | 15.20 | - | 57.07 | 23.26 |
PS Ratio | 2.15 | 1.62 | 2.20 | 2.76 | 3.30 | 3.43 |